Fundraising FoxAcre Venture Partners — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Bruno Mengatti(Founder)Jose Noblecilla(Founder)Luiza Batista(Founder)Victor Bernardino(Founder)Yuri Janotti(Founder)
Co-investorsCapria VenturesMAYA Capital VenturesValor Capital GroupAcross Capital Partners
Bonsai is an all-in-one platform for agencies and small businesses that combines project management, time tracking, invoicing, and client relationship management in a single integrated system.
B2B MarketplacesEnterprise SoftwareFintechFuture of WorkSaaSBoulder, US
Matt Nish(Founder)inMatt Brown(CEO)inBenjamin Stanfield(Product Development \u0026 Design Intern)inRedon Gjika(CEO)Neha Naik(Recruiter)Anika Neil(HR)
Co-investorsBrass Ring VenturesFall Line CapitalJude GomilaMatrixSparkland CapitalY Combinator+8 more
A full-stack monitoring platform that helps developers identify performance issues and bugs in web applications through session replay and error tracking.
Developer ToolsEnterprise SoftwareSaaSSeattle, US
Jay Khatri(Cofounder, CEO (acquired by LaunchDarkly))inVadim Korolik(Founder)inEdith Harbaugh(Founder)John Kodumal(Founder)
Co-investorsAfore CapitalCraft VenturesFuel CapitalMakers FundNeoRamtin Naimi+17 more
.png){kind=avatar}
Using microbes to draw down carbon into soils at scale.
Frank Oly(Founder)Guy Hudson(Founder)Guy Webb(Chief Agronomy Officer & Co-founder)Mick Wettenhall(Founder)Tegan Nock(Founder)Rob Hranac(Chief Executive Officer (CEO))
Co-investorsArtesianHAWKTAILHorizons VenturesLowercarbon CapitalMain Sequence VenturesNSW Clean Technology Innovation Grants+4 more
People Science runs real-world clinical research for the health and wellness industry, offering a decentralized clinical trial platform (Chloe Clinical) and a real-world data collection tool (Chloe LiveLab) alongside clinical research services.
Digital HealthHealthtechWellness & Fitness
Noah Craft(Founder)in
Co-investorsFTW VenturesLifeforce CapitalNoeticBluestein VenturesSUPPLY CHANGE CAPITAL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.